Urogenital Infections Caused by Chlamydia Trachomatis

Početkom 1998. godine oformljena je grupa stručnjaka za istraživanje urogenitalnih infekcija uzrokovanih Chlamydiom trachomatis. Istraživanje je planirano do kraja 2002. godine. Glavna dosadašnja postignuća su u više objavljenih radova: 5 u Current Contents, 2 u Excerpta Medica, 1 u Index Medicus, jednom magisteriju, jednoj disertaciji, te prihvaćene teme za izradu još četiriju magisterija. Eventualno prepoznatljive preporuke o višim dozama azitromicina i novim indikacijama za primjenu azitromicina u području spolno prenosivih bolesti nisu službena preporuka PLIVE, nego one proizlaze iz rezultata ovog još nezavrπenog znanstvenoistraživačkog projekta. Postojeća registracija Sumameda u terapiji spolno prenosivih infekcija je 1 gram jednokratno.Early in 1998, a group of experts was formed in order to do research on urogenital infections caused by Chlamydia trachomatis. The study was planned to last till the end of 2002. Major achievements reached so far were published in several journals (indexed in the following databases: 5 in Current Contents, 2 in Excerpta Medica, one in Index Medicus), in one master’s thesis, one doctoral dissertation, and are to be reported in four additional master’s thesis. Possible recognizable recommendations for higher doses of azithromycin and new indications for azithromycin administration in the treatment of sexually transmitted diseases are not the official position of PLIVA, but they are implied by the results of this still unfinished scientific and research project. Current recommended dosage of Sumamed in the treatment of sexually transmitted infections is a single dose of 1 g